Drug maker's PR firm is force behind blood clot awareness campaign.

Ray Moynihan

doi:10.1136/bmj.a502

Drug maker's PR firm is force behind blood clot awareness campaign.

Ray Moynihan^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Article › Professional

4 Citations (Scopus)

Abstract

The international public relations firm Fleishman-Hillard, working with funds from the drug maker Sanofi-Aventis, is helping run a high profile campaign to raise public awareness about blood clots.

The campaign, currently running in Australia under the banner of a coalition of health professionals, has generated headlines claiming that blood clots are more deadly than AIDS and articles suggesting that injections for patients at risk of developing clots may become mandatory.

Original language	English
Pages (from-to)	1460-1461
Number of pages	2
Journal	BMJ (Clinical research ed.)
Volume	336
Issue number	7659
DOIs	https://doi.org/10.1136/bmj.a502
Publication status	Published - 28 Jun 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/bmj.a502

Cite this

@article{48513a0034ea47529a2658e4a6544286,

title = "Drug maker's PR firm is force behind blood clot awareness campaign.",

abstract = "The international public relations firm Fleishman-Hillard, working with funds from the drug maker Sanofi-Aventis, is helping run a high profile campaign to raise public awareness about blood clots. The campaign, currently running in Australia under the banner of a coalition of health professionals, has generated headlines claiming that blood clots are more deadly than AIDS and articles suggesting that injections for patients at risk of developing clots may become mandatory.",

author = "Ray Moynihan",

year = "2008",

month = jun,

day = "28",

doi = "10.1136/bmj.a502",

language = "English",

volume = "336",

pages = "1460--1461",

journal = "BMJ (Clinical research ed.)",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

number = "7659",

}

TY - JOUR

T1 - Drug maker's PR firm is force behind blood clot awareness campaign.

AU - Moynihan, Ray

PY - 2008/6/28

Y1 - 2008/6/28

N2 - The international public relations firm Fleishman-Hillard, working with funds from the drug maker Sanofi-Aventis, is helping run a high profile campaign to raise public awareness about blood clots. The campaign, currently running in Australia under the banner of a coalition of health professionals, has generated headlines claiming that blood clots are more deadly than AIDS and articles suggesting that injections for patients at risk of developing clots may become mandatory.

AB - The international public relations firm Fleishman-Hillard, working with funds from the drug maker Sanofi-Aventis, is helping run a high profile campaign to raise public awareness about blood clots. The campaign, currently running in Australia under the banner of a coalition of health professionals, has generated headlines claiming that blood clots are more deadly than AIDS and articles suggesting that injections for patients at risk of developing clots may become mandatory.

UR - https://www.scopus.com/pages/publications/47749101605

U2 - 10.1136/bmj.a502

DO - 10.1136/bmj.a502

M3 - Article

C2 - 18583665

AN - SCOPUS:47749101605

SN - 0959-535X

VL - 336

SP - 1460

EP - 1461

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

IS - 7659

ER -

Drug maker's PR firm is force behind blood clot awareness campaign.

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this